Old Web
English
Sign In
Acemap
>
authorDetail
>
Matthew Gormley
Matthew Gormley
The Ohio State University Wexner Medical Center
Immunology
Regulatory T cell
T cell
Biology
CD20
4
Papers
68
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
B cell depletion changes the immune cell profile in multiple sclerosis patients: One-year report.
2021
Journal of Neuroimmunology
Amy E. Lovett-Racke
Yuhong Yang
Yue Liu
Matthew Gormley
Emma E. Kraus
Calsey Graham
Sibyl Wray
Michael K. Racke
Enrique Alvarez
Ann D Bass
Edward Fox
Show All
Source
Cite
Save
Citations (0)
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis:
2020
Multiple Sclerosis Journal
Edward Fox
Amy E. Lovett-Racke
Matthew Gormley
Yue Liu
Maria Petracca
Sirio Cocozza
Richard A. Shubin
Sibyl Wray
Michael S. Weiss
Jenna A Bosco
Sean A Power
Koby Mok
Matilde Inglese
Show All
Source
Cite
Save
Citations (23)
B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients
2019
Journal of Neuroimmunology
Amy E. Lovett-Racke
Matthew Gormley
Yue Liu
Yuhong Yang
Calsey Graham
Sibyl Wray
Michael K. Racke
Richard A. Shubin
Cary Twyman
Enrique Alvarez
Ann Bass
James Eubanks
Edward Fox
Show All
Source
Cite
Save
Citations (18)
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis
2016
Brain
Mary E. Severin
Priscilla W. Lee
Yue Liu
Amanda J. Selhorst
Matthew Gormley
Wei Pei
Yuhong Yang
Mireia Guerau-de-Arellano
Michael K. Racke
Amy E. Lovett-Racke
Show All
Source
Cite
Save
Citations (27)
1